About the role
About Varda
Low Earth orbit is open for business. Varda is accelerating the development of commercial space infrastructure, from in-orbit pharmaceutical processing to reliable and economical reentry capsules. Varda’s W-Series vehicles are built, designed, and operated by Varda in-house, including the pharmaceutical processing payloads, the capsules, the C-PICA heat shields, and the satellite buses.
From life-saving pharmaceuticals to more powerful fiber optics, there is a world of products used on Earth today that can only be manufactured in space. Varda is accelerating innovation in the orbital economy by creating both the products and infrastructure needed so space can directly benefit life on Earth. Our mission is to expand the economic bounds of humankind.
Our team is uniquely suited to accomplishing this goal, with leadership and staff comprised of veterans from SpaceX, Blue Origin, major pharmaceutical companies and Silicon Valley. Varda was founded in January 2021 by Will Bruey and Delian Asparouhov with significant backing from world class investors including Khosla Ventures, Lux Capital, Founders Fund, Caffeinated Capital, General Catalyst, and Also Capital.
Varda is headquartered in El Segundo, California, where we have offices and a production facility where our vehicles, equipment, and materials are built, integrated, and tested. Varda also has offices in Washington, DC and Huntsville, AL.
Join Varda, and work to create a bustling in-space ecosystem.
About this Role
Our pharmaceutical team is looking for a highly motivated and effective Manager who will lead the Crystallization Screening Team towards our efforts in improving therapeutics with microgravity. This is an opportunity in an exciting area of growth for Varda, where you will get to shape Varda’s biopharma culture and will play a significant role in establishing the low Earth orbit economy.
Responsibilities
- Oversee crystallization screening and characterization of molecules for microgravity opportunities across a diverse range of modalities including small molecules and biologics.